Literature DB >> 12235234

Analgesic effects of intrathecal administration of P2Y nucleotide receptor agonists UTP and UDP in normal and neuropathic pain model rats.

Maiko Okada1, Takayuki Nakagawa, Masabumi Minami, Masamichi Satoh.   

Abstract

Recent electrophysiological, behavioral, and biochemical studies revealed that ATP plays a role in facilitating spinal pain transmission via ionotropic P2X nucleotide receptors, although the involvement of metabotropic P2Y nucleotide receptors remains unclear. In the present study, we examined the effects of i.t. administration of P2Y receptor agonists UTP, UDP, and related compounds on nociception in normal rats and tactile allodynia in a neuropathic pain model. In the paw pressure test using normal rats, i.t. administration of UTP (30 and 100 nmol/rat) and UDP (30 and 100 nmol/rat), but not UMP (100 nmol/rat) or uridine (100 nmol/rat), significantly elevated the mechanical nociceptive thresholds, whereas ATP (30 and 100 nmol/rat) and alpha,beta-methylene-ATP (10 and 30 nmol/rat) lowered them. Similarly, in the tail-flick test, UTP (10, 30, and 100 nmol/rat) and UDP (100 nmol/rat) significantly prolonged the thermal nociceptive latency. In the von Frey filament test on normal rats, UTP (100 nmol/rat) and UDP (100 nmol/rat) produced no allodynia to the tactile stimulus, whereas ATP (100 nmol/rat) induced a significant and long-lasting tactile allodynia. In the neuropathic pain model, in which the sciatic nerves of rats were partially ligated, UTP (30 and 100 nmol/rat) and UDP (30 and 100 nmol/rat) produced significant antiallodynic effects. Furthermore, UTP (100 nmol/rat) and UDP (100 nmol/rat) caused no motor deficit in the inclined plane test. Taken together, these results suggest that the activation of UTP-sensitive P2Y(2) and/or P2Y(4) receptors and the UDP-sensitive P2Y(6) receptor, in contrast to P2X receptors, produces inhibitory effects on spinal pain transmission.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12235234     DOI: 10.1124/jpet.102.036079

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  27 in total

Review 1.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 2.  P2X3 receptor involvement in pain states.

Authors:  Kerstin Wirkner; Beata Sperlagh; Peter Illes
Journal:  Mol Neurobiol       Date:  2007-07-17       Impact factor: 5.590

3.  Chronic inflammatory pain upregulates expression of P2Y2 receptor in small-diameter sensory neurons.

Authors:  Huiqin Zhu; Yi Yu; Lingyan Zheng; Lu Wang; Chenli Li; Jiangyuan Yu; Jing Wei; Chuang Wang; Junfang Zhang; Shujun Xu; Xiaofei Wei; Wei Cui; Qinwen Wang; Xiaowei Chen
Journal:  Metab Brain Dis       Date:  2015-06-12       Impact factor: 3.584

4.  Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain.

Authors:  Steve McGaraughty; Prisca Honore; Carol T Wismer; Joseph Mikusa; Chang Z Zhu; Heath A McDonald; Bruce Bianchi; Connie R Faltynek; Michael F Jarvis
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

Review 5.  Crossing the pain barrier: P2 receptors as targets for novel analgesics.

Authors:  C Kennedy; T S Assis; A J Currie; E G Rowan
Journal:  J Physiol       Date:  2003-09-26       Impact factor: 5.182

6.  Altered mitochondrial ATP synthase expression in the rat dorsal root ganglion after sciatic nerve injury and analgesic effects of intrathecal ATP.

Authors:  Kuan-Hung Chen; Chung-Ren Lin; Jiin-Tsuey Cheng; Jen-Kun Cheng; Wen-Tzu Liao; Chien-Hui Yang
Journal:  Cell Mol Neurobiol       Date:  2013-09-19       Impact factor: 5.046

7.  P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain.

Authors:  Kimiko Kobayashi; Hiroki Yamanaka; Tetsuo Fukuoka; Yi Dai; Koichi Obata; Koichi Noguchi
Journal:  J Neurosci       Date:  2008-03-12       Impact factor: 6.167

Review 8.  Emerging peripheral receptor targets for deep-tissue craniofacial pain therapies.

Authors:  R Ambalavanar; D Dessem
Journal:  J Dent Res       Date:  2009-03       Impact factor: 6.116

9.  Effects of A-317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration.

Authors:  Steve McGaraughty; Carol T Wismer; Chang Z Zhu; Joseph Mikusa; Prisca Honore; Katharine L Chu; Chih-Hung Lee; Connie R Faltynek; Michael F Jarvis
Journal:  Br J Pharmacol       Date:  2003-11-17       Impact factor: 8.739

10.  Gene transfer of GLT-1, a glial glutamate transporter, into the spinal cord by recombinant adenovirus attenuates inflammatory and neuropathic pain in rats.

Authors:  Sanae Maeda; Ai Kawamoto; Yumi Yatani; Hisashi Shirakawa; Takayuki Nakagawa; Shuji Kaneko
Journal:  Mol Pain       Date:  2008-12-24       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.